Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were...
Stay updated with breaking news from Diagnostic Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were...
The Agency for Healthcare Research and Quality is recruiting providers to participate in a new effort to ensure safety when diagnosing cancer via virtual care. The results will also help shape approaches to other diseases.
The American Thoracic Society will develop an education program focused on safety and equity at the time of ICU discharge.
Seventeen abstracts debut new data across narcolepsy and idiopathic hypersomnia DUBLIN, June 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 17 new abstracts from across its...